To understand the relation of the activation status of SHP2 and ERK/NF-κB pathway in human DN pathology, we performed immunostaining of p-SHP2, p-ERK and p-NF-κB on human DN samples through IHC (Fig. 8A), and further analyzed the correlation between their expression levels. The gene discussed is PTPN11; the disease is liver dysplastic nodule.